Asucan, Gloria D.

HRN: 29-02-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
CEFTRIAXONE 1G (VIAL)
05/22/2026
05/29/2026
IV
2g
OD
Intrabdominal Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: